These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 27796709)

  • 1. Effects of somatostatin and its analogues on progenitor mesenchymal cells isolated from human pituitary adenomas.
    Orciani M; Caffarini M; Sorgentoni G; Ricciuti RA; Arnaldi G; Di Primio R
    Pituitary; 2017 Apr; 20(2):251-260. PubMed ID: 27796709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Arrestin 1 and 2 and G protein-coupled receptor kinase 2 expression in pituitary adenomas: role in the regulation of response to somatostatin analogue treatment in patients with acromegaly.
    Gatto F; Feelders R; van der Pas R; Kros JM; Dogan F; van Koetsveld PM; van der Lelij AJ; Neggers SJ; Minuto F; de Herder W; Lamberts SW; Ferone D; Hofland LJ
    Endocrinology; 2013 Dec; 154(12):4715-25. PubMed ID: 24169548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues--Observations in two patients with acromegaly and severe headache.
    Marina D; Burman P; Klose M; Casar-Borota O; Luque RM; Castaño JP; Feldt-Rasmussen U
    Growth Horm IGF Res; 2015 Oct; 25(5):262-7. PubMed ID: 26188991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of selective somatostatin analogs and cortistatin on cell viability in cultured human non-functioning pituitary adenomas.
    Padova H; Rubinfeld H; Hadani M; Cohen ZR; Nass D; Taylor JE; Culler MD; Shimon I
    Mol Cell Endocrinol; 2008 May; 286(1-2):214-8. PubMed ID: 18276067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells.
    Modarai SR; Opdenaker LM; Viswanathan V; Fields JZ; Boman BM
    BMC Cancer; 2016 Dec; 16(1):941. PubMed ID: 27927191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling identifies ESRP1 as a potential regulator of epithelial mesenchymal transition in somatotroph adenomas from a large cohort of patients with acromegaly.
    Lekva T; Berg JP; Fougner SL; Olstad OK; Ueland T; Bollerslev J
    J Clin Endocrinol Metab; 2012 Aug; 97(8):E1506-14. PubMed ID: 22585092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary adenomas, stem cells, and cancer stem cells: what's new?
    Caffarini M; Orciani M; Trementino L; Di Primio R; Arnaldi G
    J Endocrinol Invest; 2018 Jul; 41(7):745-753. PubMed ID: 29222642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of stromal cell-derived factor 1 and its receptor CXCR4 induces autocrine/paracrine cell proliferation in human pituitary adenomas.
    Barbieri F; Bajetto A; Stumm R; Pattarozzi A; Porcile C; Zona G; Dorcaratto A; Ravetti JL; Minuto F; Spaziante R; Schettini G; Ferone D; Florio T
    Clin Cancer Res; 2008 Aug; 14(16):5022-32. PubMed ID: 18698020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptor-specific analogs: effects on cell proliferation and growth hormone secretion in human somatotroph tumors.
    Danila DC; Haidar JN; Zhang X; Katznelson L; Culler MD; Klibanski A
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2976-81. PubMed ID: 11443154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and characterization of progenitor mesenchymal cells in human pituitary tumors.
    Orciani M; Davis S; Appolloni G; Lazzarini R; Mattioli-Belmonte M; Ricciuti RA; Boscaro M; Di Primio R; Arnaldi G
    Cancer Gene Ther; 2015 Jan; 22(1):9-16. PubMed ID: 25525036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.
    Hubina E; Nanzer AM; Hanson MR; Ciccarelli E; Losa M; Gaia D; Papotti M; Terreni MR; Khalaf S; Jordan S; Czirják S; Hanzély Z; Nagy GM; Góth MI; Grossman AB; Korbonits M
    Eur J Endocrinol; 2006 Aug; 155(2):371-9. PubMed ID: 16868153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relevance of coexpression of somatostatin and dopamine D2 receptors in pituitary adenomas.
    Saveanu A; Jaquet P; Brue T; Barlier A
    Mol Cell Endocrinol; 2008 May; 286(1-2):206-13. PubMed ID: 18241980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ursolic acid inhibits the proliferation of human ovarian cancer stem-like cells through epithelial-mesenchymal transition.
    Zhang J; Wang W; Qian L; Zhang Q; Lai D; Qi C
    Oncol Rep; 2015 Nov; 34(5):2375-84. PubMed ID: 26323892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of hormone secretion in GH-secreting pituitary adenomas by receptor-subtype specific somatostatin analogues in vitro.
    Cap J; Marekova M; Cerman J; Malirova E; Suba P; Netuka D; Hana V; Marek J
    Gen Physiol Biophys; 2003 Jun; 22(2):201-12. PubMed ID: 14661732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential inhibitory role for the new truncated variant of somatostatin receptor 5, sst5TMD4, in pituitary adenomas poorly responsive to somatostatin analogs.
    Durán-Prado M; Saveanu A; Luque RM; Gahete MD; Gracia-Navarro F; Jaquet P; Dufour H; Malagón MM; Culler MD; Barlier A; Castaño JP
    J Clin Endocrinol Metab; 2010 May; 95(5):2497-502. PubMed ID: 20233783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New medical treatments in pituitary adenomas].
    Drutel A; Caron P; Archambeaud F
    Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S16-28. PubMed ID: 18954854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine receptor type 2 (DRD2) and somatostatin receptor type 2 (SSTR2) agonists are effective in inhibiting proliferation of progenitor/stem-like cells isolated from nonfunctioning pituitary tumors.
    Peverelli E; Giardino E; Treppiedi D; Meregalli M; Belicchi M; Vaira V; Corbetta S; Verdelli C; Verrua E; Serban AL; Locatelli M; Carrabba G; Gaudenzi G; Malchiodi E; Cassinelli L; Lania AG; Ferrero S; Bosari S; Vitale G; Torrente Y; Spada A; Mantovani G
    Int J Cancer; 2017 Apr; 140(8):1870-1880. PubMed ID: 28120505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid pituitary tumor shrinkage with dissociation between antiproliferative and antisecretory effects of a long-acting octreotide in an acromegalic patient.
    Resmini E; Dadati P; Ravetti JL; Zona G; Spaziante R; Saveanu A; Jaquet P; Culler MD; Bianchi F; Rebora A; Minuto F; Ferone D
    J Clin Endocrinol Metab; 2007 May; 92(5):1592-9. PubMed ID: 17311860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversion of malignant phenotypes of human glioblastoma cells by β-elemene through β-catenin-mediated regulation of stemness-, differentiation- and epithelial-to-mesenchymal transition-related molecules.
    Zhu T; Li X; Luo L; Wang X; Li Z; Xie P; Gao X; Song Z; Su J; Liang G
    J Transl Med; 2015 Nov; 13():356. PubMed ID: 26563263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.